The authors aimed to examine whether participation in Medicare managed care, compared with fee-for-service, has any effects on racial/ethnic disparities in diabetes care and healthcare expenditures among older adults.
The authors propose a simple legal mechanism to combat chargemaster abuses and encourage provider price competition. This solution is superior to prevailing legislative and regulatory responses to surprise out-of-network bills.
Nurses can improve lipid control in people with diabetes in a primarily indigent population through telephone care using moderately complex algorithms. Telephone-based outreach may decrease resource utilization.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Patients often self-refer to the emergency department (ED) for management of an ambulatory care–sensitive condition, and the ED may be the most appropriate care location.
Among HIV-positive Medicaid patients with comorbid medical and psychiatric disorders, there was increased outpatient service utilization, yet relative cost savings, for patients who were treated in patient-centered medical homes.
Perceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.
Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.
Patients who used workplace primary care and pharmacy services had higher adherence rates to medications for their chronic conditions than community-treated patients.
This study demonstrates a major influence of prehypertension and hypertension on healthcare costs in a large cohort of children, independent of body mass index.
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.